Google Chrome
Safari
Firefox
Edge
Press Clipping / Sep 23, 2020
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
Business Wire, September 23, 2020
Search
Press Clipping / Sep 23, 2020
Hovione to support production of antiviral Veklury for COVID-19
Manufacturing Chemist, September 23, 2020
Press Clipping / Sep 23, 2020
Hovione Announces Partnership to Produce Ligand’s Captisol; Used in Gilead’s Covid-19 Treatment
Drug Development & Delivery, September 23, 2020
Hovione at a glance
Get to know more about our history
Explore what we do
Hovione is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.
Virtual Tours
Our doors are open. Welcome to our facilities. We are a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.
Press Clipping / Oct 02, 2020
Pharma manufacturer Hovione announces 48 new jobs for Cork
Silicon Republic, October 2, 2020
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Article / Oct 23, 2020
Technical advances towards the industrial application of transaminases for the synthesis of chiral amines
Chimica Oggi-Chemistry Today, September/October 2020